Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 8/20 | 0.66 |
| ▸ | NPC1 | O15118 | 6/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.66 |
| ▸ | APP | P05067 | 5/20 | 0.64 |
| ▸ | MAPT | P10636 | 3/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.64 |
| ▸ | GLA | P06280 | 2/20 | 0.64 |
| ▸ | GAA | P10253 | 2/20 | 0.64 |
| ▸ | MMP9 | P14780 | 2/20 | 0.64 |
| ▸ | MMP8 | P22894 | 2/20 | 0.64 |
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | MEN1 | O00255 | 4/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | PKM | P14618 | 1/20 | 0.58 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.58 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.58 |
| ▸ | TNF | P01375 | 1/20 | 0.58 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 2-Phenylbenzo[D]Thiazole SCHEMBL27839442 | 0.86 | RAB9A (0.72) | RAB9ANPC1KDM4EAPPMAPT | |
| SCHEMBL366824 | 0.86 | RAB9A (0.81) | RAB9ANPC1KDM4EAPPMAPT | |
| SCHEMBL29474819 | 0.86 | RAB9A (0.81) | RAB9ANPC1KDM4EAPPMAPT | |
| SCHEMBL24295138 | 0.84 | RAB9A (0.79) | RAB9ANPC1KDM4EAPPMAPT | |
| 2-Phenylbenzo[D]Thiazole SCHEMBL94005 | 0.84 | RAB9A (0.75) | RAB9ANPC1KDM4EAPPMAPT | |
| 2-Phenylbenzo[D]Thiazole SCHEMBL30988131 | 0.84 | RAB9A (0.75) | RAB9ANPC1KDM4EAPPMAPT | |
| 2-Phenylbenzo[D]Thiazole SCHEMBL29986751 | 0.82 | RAB9A (0.72) | RAB9ANPC1KDM4EAPPMAPT | |
| 2-Phenylbenzo[D]Thiazole SCHEMBL2453217 | 0.82 | RAB9A (0.72) | RAB9ANPC1KDM4EAPPMAPT | |
| 2-Phenylbenzo[D]Thiazole SCHEMBL29928313 | 0.82 | RAB9A (0.72) | RAB9ANPC1KDM4EAPPMAPT | |
| 2-Phenylbenzo[D]Thiazole SCHEMBL27949942 | 0.82 | RAB9A (0.72) | RAB9ANPC1KDM4EAPPMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 203 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9112159-B2 | Bipolar hosts for light emitting devices | NITTO DENKO CORPORATION (JP) | 2015-08-18 | — | — | US | claimed |
| WO-2014093361-A1 | BIPOLAR HOSTS FOR LIGHT EMITTING DEVICES | NITTO DENKO CORPORATION (JP) | 2014-06-19 | — | — | WO | claimed |
| US-20140163237-A1 | BIPOLAR HOSTS FOR LIGHT EMITTING DEVICES | Nitto Denko Corportion (JP) | 2014-06-12 | — | — | US | claimed |
| CN-102239150-A | Novel indazole derivatives or pharmaceutically acceptable salts thereof as protein kinase inhibitors for proliferative diseases treatment, and a pharmaceutical composition containing the same as an active ingredient | KOREA INST SCI & TECH | 2011-11-09 | — | — | CN | claimed |
| WO-2011049274-A1 | IMIDAZOLE DERIVATIVES AND COMPOSITIONS FOR TREATING MELANOMA | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2011-04-28 | — | — | WO | claimed |
| WO-2007135529-A2 | AZABENZIMIDAZOLYL COMPOUNDS AS MGLUR2 POTENTIATORS | PFIZER PRODUCTS INC. (US) | 2007-11-29 | — | — | WO | claimed |
| EP-0770079-B1 | HETEROBICYCLIC DERIVATIVES | FUJISAWA PHARMACEUTICAL CO (JP) | 2003-02-12 | — | — | EP | claimed |
| US-20020107251-A1 | Heterobicyclic derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-08-08 | — | — | US | claimed |
| US-6426345-B1 | PHOSPHODIESTERASE INHIBITORS; ANTIINFLAMMATORY AGENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-07-30 | — | — | US | claimed |
| CN-1157617-A | Heterobicyclic derivatives | FUJISAWA PHARMACEUTICAL CO (JP) | 1997-08-20 | — | — | CN | claimed |
| EP-0770079-A1 | HETEROBICYCLIC DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-05-02 | — | — | EP | claimed |
| WO-1996001825-A1 | HETEROBICYCLIC DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-01-25 | — | — | WO | claimed |
| EP-0674635-A1 | QUINUCLIDINE DERIVATIVES AS SQUALENE SYNTHASE INHIBITORS | ZENECA LIMITED (GB) | 1995-10-04 | — | — | EP | claimed |
| WO-1994014803-A1 | QUINUCLIDINE DERIVATIVES AS SQUALENE SYNTHASE INHIBITORS | ZENECA LIMITED (GB) | 1994-07-07 | — | — | WO | claimed |
| US-4665162-A | DYES FOR LEATHER AND PAPER | SANDOZ LTD. (CH) | 1987-05-12 | — | — | US | claimed |
| EP-0105027-B1 | REACTIVE DYES, THEIR PREPARATION AND THEIR USE | CIBA-GEIGY AG (CH) | 1987-05-06 | — | — | EP | claimed |
| EP-0073387-B1 | WATER-SOLUBLE POLYAZO DYESTUFFS, THEIR PREPARATION AND THEIR USE | CASSELLA Aktiengesellschaft (DE) | 1984-12-27 | — | — | EP | claimed |
| US-4485042-A | COLORFASTNESS | CASSELLA AKTIENGESELLSCHAFT (DE) | 1984-11-27 | — | — | US | claimed |
| US-3933787-A | DYEING AND PRINTING PAPER | SANDOZ LTD., (SANDOZ AG) (CH) | 1976-01-20 | — | — | US | claimed |
| CN-113816909-B | Organic electroluminescent material containing phenanthrene structure and device thereof | 武汉尚赛光电科技有限公司 | 2023-07-11 | — | — | CN | disclosed |
| US-20230201161-A1 | Combination comprising HDAC inhibitor, LAG-3 inhibitor and a PD-1 inhibitor or PD-L1 inhibitor for cancer treatment | 4SC AG (DE) | 2023-06-29 | — | — | US | disclosed |
| CN-111285809-B | Green synthesis method of imidazoline under visible light catalysis | 杭州师范大学 | 2023-04-25 | — | — | CN | disclosed |
| CN-109791984-B | Material for photoelectric conversion element for imaging element and photoelectric conversion element containing same | 日本化药株式会社 | 2023-02-07 | — | — | CN | disclosed |
| CN-115207257-A | Light emitting device and electronic apparatus including the same | 三星显示有限公司 | 2022-10-18 | — | — | CN | disclosed |
| CN-114616228-A | Compound, polymerizable composition, polymer, hologram recording medium, optical material, and optical member | 三菱化学株式会社 | 2022-06-10 | — | — | CN | disclosed |
| CN-109897031-B | Benzothiazole derivative containing coumarin group and preparation method and application thereof | 南京农业大学 | 2022-03-15 | — | — | CN | disclosed |
| US-20210145799-A1 | PHARMACEUTICAL COMBINATION PRODUCTS COMPRISING A HISTONE DEACETYLASE (HDAC) INHIBITOR AND A TLR7 AGONIST AND/OR TLR8 AGONIST FOR THE TREATMENT OF CANCER | 4SC AG (DE) | 2021-05-20 | — | — | US | disclosed |
| US-20210113528-A1 | Combination comprising HDAC inhibitor and CD137 agonist for cancer therapy | 4SC AG (DE) | 2021-04-22 | — | — | US | disclosed |
| WO-2021064188-A1 | COMBINATION COMPRISING HDAC INHIBITOR, CTLA-4 INHIBITOR AND A PD-1 INHIBITOR OR PD-L1 INHIBITOR FOR CANCER TREATMENT | 4SC AG (DE) | 2021-04-08 | — | — | WO | disclosed |
| CN-112521369-A | Compounds and compositions for inhibition of FASN | 福马治疗股份有限公司 | 2021-03-19 | — | — | CN | disclosed |
| EP-3781557-A1 | PHARMACEUTICAL COMBINATION PRODUCTS COMPRISING A HISTONE DEACETYLASE (HDAC) INHIBITOR AND A TLR7 AGONIST AND/OR TLR8 AGONIST FOR THE TREATMENT OF CANCER | 4SC AG (DE) | 2021-02-24 | — | — | EP | disclosed |
| EP-3781159-A1 | COMBINATION COMPRISING HDAC INHIBITOR, LAG-3 INHIBITOR AND A PD-1 INHIBITOR OR PD-L1 INHIBITOR FOR CANCER TREATMENT | 4SC AG (DE) | 2021-02-24 | — | — | EP | disclosed |
| EP-3773554-A1 | COMBINATION COMPRISING HDAC INHIBITOR AND CD137 AGONIST FOR CANCER THERAPY | 4SC AG (DE) | 2021-02-17 | — | — | EP | disclosed |
| CN-107430340-B | Colored photosensitive composition, cured film, pattern formation method, infrared cut color filter with light-shielding film, solid-state imaging element, image display device, and infrared sensor | 富士胶片株式会社 | 2021-01-01 | — | — | CN | disclosed |
| CN-112105611-A | Pharmaceutical combination comprising a Histone Deacetylase (HDAC) inhibitor and a TLR7 agonist and/or a TLR8 agonist for the treatment of cancer | 4SC股份公司 | 2020-12-18 | — | — | CN | disclosed |
| CN-112055589-A | Combination comprising an HDAC inhibitor, a LAG-3 inhibitor and a PD-1 inhibitor or a PD-L1 inhibitor for the treatment of cancer | 4SC股份公司 | 2020-12-08 | — | — | CN | disclosed |
| CN-112004535-A | Combination comprising an HDAC inhibitor and a CD137 agonist for cancer therapy | 4SC股份公司 | 2020-11-27 | — | — | CN | disclosed |
| CN-105492008-B | Compounds and compositions for inhibition of FASN | 福马治疗股份有限公司 | 2020-11-27 | — | — | CN | disclosed |
| US-20200261418-A1 | HDAC INHIBITOR IN COMBINATION WITH IMMUNE CHECKPOINT MODULATOR FOR CANCER THERAPY | 4SC AG (DE) | 2020-08-20 | — | — | US | disclosed |
| CN-111432884-A | Combination of HDAC inhibitors with immune checkpoint modulators for cancer therapy | 4SC股份公司 | 2020-07-17 | — | — | CN | disclosed |
| EP-3678740-A1 | HDAC INHIBITOR IN COMBINATION WITH IMMUNE CHECKPOINT MODULATOR FOR CANCER THERAPY | 4SC AG (DE) | 2020-07-15 | — | — | EP | disclosed |
| WO-2019202001-A1 | COMBINATION COMPRISING HDAC INHIBITOR, LAG-3 INHIBITOR AND A PD-1 INHIBITOR OR PD-L1 INHIBITOR FOR CANCER TREATMENT | 4SC AG (DE) | 2019-10-24 | — | — | WO | disclosed |
| WO-2019200238-A1 | COMBINATIONS INCLUDING A CPG-C TYPE OLIGONUCLEOTIDE AND A HISTONE DEACETYLASE INHIBITOR FOR TREATING CANCER | DYNAVAX TECHNOLOGIES CORPORATION (US) | 2019-10-17 | — | — | WO | disclosed |
| WO-2019197682-A1 | PHARMACEUTICAL COMBINATION PRODUCTS COMPRISING A HISTONE DEACETYLASE (HDAC) INHIBITOR AND A TLR7 AGONIST AND/OR TLR8 AGONIST FOR THE TREATMENT OF CANCER | 4SC AG (DE) | 2019-10-17 | — | — | WO | disclosed |
| WO-2019185598-A1 | COMBINATION COMPRISING HDAC INHIBITOR AND CD137 AGONIST FOR CANCER THERAPY | 4SC AG (DE) | 2019-10-03 | — | — | WO | disclosed |
| CN-110023303-A | Tetrazolinone compounds and their use as pest control agents | 住友化学株式会社 | 2019-07-16 | — | — | CN | disclosed |
| CN-109897031-A | A kind of benzothiazole analog derivative and the preparation method and application thereof containing coumarin group | 南京农业大学 | 2019-06-18 | — | — | CN | disclosed |
| US-10243151-B2 | Organic semiconductor material and light-emitting element, light-emitting device, lighting system, and electronic device using the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2019-03-26 | — | — | US | disclosed |
| WO-2019048629-A1 | HDAC INHIBITOR IN COMBINATION WITH IMMUNE CHECKPOINT MODULATOR FOR CANCER THERAPY | 4SC AG (DE) | 2019-03-14 | — | — | WO | disclosed |
| CN-106319623-B | It is a kind of silver iodo hydridization second-order non-linear optical materials and its synthesis and application | 济南大学 | 2018-09-11 | — | — | CN | disclosed |
| CN-108456161-A | Phenyl indene compounds, organic electroluminescence device and display device | 王美妮 | 2018-08-28 | — | — | CN | disclosed |
| CN-108218788-A | A kind of phenyl indene compounds, organic electroluminescence device and display device | 阜阳欣奕华材料科技有限公司 | 2018-06-29 | — | — | CN | disclosed |
| CN-107721947-A | A kind of green clean synthesis process for producing benzothiazole | 河南恒瑞橡塑科技股份有限公司 | 2018-02-23 | — | — | CN | disclosed |
| US-20170250352-A1 | Organic Semiconductor Material and Light-Emitting Element, Light-Emitting Device, Lighting System, and Electronic Device Using the Same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-08-31 | — | — | US | disclosed |
| US-9624193-B2 | Cyclic azine derivatives, processes for producing these, and organic electroluminescent element containing these as component | TOSOH CORPORATION (JP) | 2017-04-18 | — | — | US | disclosed |
| US-9620723-B2 | Organic semiconductor material and light-emitting element, light-emitting device, lighting system, and electronic device using the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2017-04-11 | — | — | US | disclosed |
| EP-2772483-B1 | 4-AMINOCARBAZOLE COMPOUND AND USE OF SAME | TOSOH CORP (JP) | 2017-03-29 | — | — | EP | disclosed |
| CN-106349184-A | Preparation method of 2- (ortho-alkylaryl) benzothiazole series | 江西师范大学 | 2017-01-25 | — | — | CN | disclosed |
| US-9434720-B2 | Pyrazolylbenzothiazole derivatives and their use as therapeutic agents | DIRMIRA (CANADA), INC. (US) | 2016-09-06 | — | — | US | disclosed |
| CN-104011022-B | 4-aminocarbazole compound and application thereof | 东曹株式会社 | 2016-08-24 | — | — | CN | disclosed |
| CN-105492008-A | Novel compounds and compositions for inhibition of fasn | FORMA THERAPEUTICS INC | 2016-04-13 | — | — | CN | disclosed |
| CN-103022377-B | A kind of OLED | WEIXINNUO DISPLAY TECH CO., LTD. (CN) | 2015-12-23 | — | — | CN | disclosed |
| US-20150329544-A1 | CYCLIC AZINE DERIVATIVES, PROCESSES FOR PRODUCING THESE, AND ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THESE AS COMPONENT | TOSOH CORPORATION (JP) | 2015-11-19 | — | — | US | disclosed |
| US-9172045-B2 | 4-aminocarbazole compound and use thereof | TOSOH CORPORATION (JP) | 2015-10-27 | — | — | US | disclosed |
| US-9120773-B2 | Cyclic azine derivatives, processes for producing these, and organic electroluminescent element containing these as component | TOSOH CORPORATION (JP) | 2015-09-01 | — | — | US | disclosed |
| US-20150239880-A1 | LIGHT EMITTING MATERIAL, COMPOUND, AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | UNIV KYUSHU NAT UNIV CORP (JP) | 2015-08-27 | — | — | US | disclosed |
| US-9112159-B2 | Bipolar hosts for light emitting devices | NITTO DENKO CORPORATION (JP) | 2015-08-18 | — | — | US | disclosed |
| CN-103022376-B | A kind of OLED | WEIXINNUO DISPLAY TECH CO., LTD. (CN) | 2015-08-12 | — | — | CN | disclosed |
| EP-2818462-A1 | Cyclic azine derivatives, processes for producing these, and organic electrolumiscent element containing these as component | TOSOH CORPORATION (JP) | 2014-12-31 | — | — | EP | disclosed |
| CN-102245725-B | Activator for two-part cyanoacrylate adhesives | HENKEL IRELAND LTD | 2014-12-03 | — | — | CN | disclosed |
| US-20140350009-A1 | PYRAZOLYLBENZOTHIAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | DERMIRA (CANADA), INC. (US) | 2014-11-27 | — | — | US | disclosed |
| EP-2321862-B1 | ORGANIC SEMICONDUCTOR MATERIAL AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, LIGHTING SYSTEM, AND ELECTRONIC DEVICE USING THE SAME | SEMICONDUCTOR ENERGY LAB (JP) | 2014-11-19 | — | — | EP | disclosed |
| US-20140296519-A1 | 4-AMINOCARBAZOLE COMPOUND AND USE THEREOF | TOSOH CORPORATION (JP) | 2014-10-02 | — | — | US | disclosed |
| EP-2772483-A1 | 4-AMINOCARBAZOLE COMPOUND AND USE OF SAME | Tosoh Corporation (JP) | 2014-09-03 | — | — | EP | disclosed |
| CN-104011022-A | 4-aminocarbazole compound and use of same | TOSOH CORP | 2014-08-27 | — | — | CN | disclosed |
| US-8815855-B2 | N-sulphonylpyrroles and their use as histone deacetylase inhibitors | 4SC AG (DE) | 2014-08-26 | — | — | US | disclosed |
| CN-102144313-B | Organic semiconductor material, light-emitting element, light-emitting device, lighting system, and electronic device using same | SEMICONDUCTOR ENERGY LAB | 2014-07-30 | — | — | CN | disclosed |
| US-8771843-B2 | Fluorene derivative, organic compound, and light-emitting element, light-emitting device, and electronic device using the compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-07-08 | — | — | US | disclosed |
| WO-2014093361-A1 | BIPOLAR HOSTS FOR LIGHT EMITTING DEVICES | NITTO DENKO CORPORATION (JP) | 2014-06-19 | — | — | WO | disclosed |
| US-8754233-B2 | Pyrazolylbenzothiazole derivatives and their use as therapeutic agents | DERMIRA (CANADA), INC. (US) | 2014-06-17 | — | — | US | disclosed |
| US-20140163237-A1 | BIPOLAR HOSTS FOR LIGHT EMITTING DEVICES | Nitto Denko Corportion (JP) | 2014-06-12 | — | — | US | disclosed |
| US-20130237572-A1 | PYRAZOLYLBENZOTHIAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | DERMIRA (CANADA), INC. (US) | 2013-09-12 | — | — | US | disclosed |
| EP-2619590-A2 | COMPOUNDS FOR DIAGNOSING NEURODEGENERATIVE DISEASES AT THE RETINA | Technische Universität Darmstadt (DE) | 2013-07-31 | — | — | EP | disclosed |
| US-20130112961-A1 | Organic Semiconductor Material and Light-Emitting Element, Light-Emitting Device, Lighting System, and Electronic Device Using the Same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-05-09 | — | — | US | disclosed |
| CN-103022377-A | Organic light-emitting diode (OLED) device | KUNSHAN VISIONOX DISPLAY TECH | 2013-04-03 | — | — | CN | disclosed |
| CN-103022376-A | Organic light-emitting diode (OLED) device | KUNSHAN VISIONOX DISPLAY TECH | 2013-04-03 | — | — | CN | disclosed |
| US-8410272-B2 | Pyrazolylbenzothiazole derivatives and their use as therapeutic agents | DERMIRA (CANADA), INC. (US) | 2013-04-02 | — | — | US | disclosed |
| CN-101137623-B | N-sulphonylpyrroles and use thereof as histone deacetylase inhibitors | NYCOMED GMBH | 2013-03-27 | — | — | CN | disclosed |
| US-8343639-B2 | Organic semiconductor material and light-emitting element, light-emitting device, lighting system, and electronic device using the same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-01-01 | — | — | US | disclosed |
| US-20120214993-A1 | CYCLIC AZINE DERIVATIVES, PROCESSES FOR PRODUCING THESE, AND ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THESE AS COMPONENT | SAGAMI CHEMICAL RESEARCH INSTITUTE, (JP) | 2012-08-23 | — | — | US | disclosed |
| EP-2468731-A1 | CYCLIC AZINE DERIVATIVES, PROCESSES FOR PRODUCING THESE, AND ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THESE AS COMPONENT | Tosoh Corporation (JP) | 2012-06-27 | — | — | EP | disclosed |
| WO-2012041292-A2 | COMPOUNDS FOR DIAGNOSING NEURODEGENERATIVE DISEASES AT THE RETINA | KLINIKUM DARMSTADT GMBH (DE) | 2012-04-05 | — | — | WO | disclosed |
| US-20120049768-A1 | Fluorene Derivative, Organic Compound, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Compound | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-03-01 | — | — | US | disclosed |
| CN-102245725-A | Activator for two-part cyanoacrylate adhesives | LOCTITE R & D LTD | 2011-11-16 | — | — | CN | disclosed |
| CN-102239150-A | Novel indazole derivatives or pharmaceutically acceptable salts thereof as protein kinase inhibitors for proliferative diseases treatment, and a pharmaceutical composition containing the same as an active ingredient | KOREA INST SCI & TECH | 2011-11-09 | — | — | CN | disclosed |
| CN-102144313-A | Organic semiconductor material, light-emitting element, light-emitting device, lighting system, and electronic device using same | SEMICONDUCTOR ENERGY LAB | 2011-08-03 | — | — | CN | disclosed |
| US-20110178126-A1 | PYRAZOLYLBENZOTHIAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | Valocor Therapeutics, Inc. (CA) | 2011-07-21 | — | — | US | disclosed |
| EP-2321862-A1 | ORGANIC SEMICONDUCTOR MATERIAL AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, LIGHTING SYSTEM, AND ELECTRONIC DEVICE USING THE SAME | Semiconductor Energy Laboratory Co, Ltd. (JP) | 2011-05-18 | — | — | EP | disclosed |
| WO-2011049274-A1 | IMIDAZOLE DERIVATIVES AND COMPOSITIONS FOR TREATING MELANOMA | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2011-04-28 | — | — | WO | disclosed |
| US-7847101-B2 | such as (4-Benzothiazol-2-yl-1H-pyrazol-3-yl)-[2-(1H-imidazol-4-yl)-ethyl]-amine, used in the treatment of disorders associated with hyperproliferation and tissue remodelling or repair, inflammation, cell migration and invasion, and renal diseases, or as protein kinase inhibitors | Valocor Therapeutics, Inc. (CA) | 2010-12-07 | — | — | US | disclosed |
| CN-101784634-A | Thiazole system organic electroluminescent compounds and organic light emitting diode using the same | GRACEL DISPLAY INC | 2010-07-21 | — | — | CN | disclosed |
| US-20100074862-A1 | N-SULPHONYLPYRROLES AND THEIR USE AS HISTONE DEACETYLASE INHIBITORS | MAIER THOMAS | 2010-03-25 | — | — | US | disclosed |
| WO-2010027004-A1 | ORGANIC SEMICONDUCTOR MATERIAL AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, LIGHTING SYSTEM, AND ELECTRONIC DEVICE USING THE SAME | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2010-03-11 | — | — | WO | disclosed |
| US-20100060155-A1 | Organic Semiconductor Material and Light-Emitting Element, Light-Emitting Device, Lighting System, and Electronic Device Using the Same | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2010-03-11 | — | — | US | disclosed |
| US-7666868-B2 | e.g. N-Hydroxy-3-{1-[4-(1-methyl-1H-indol-5-yl)-benzenesulfonyl]-1H-pyrrol-3-yl}-acrylamide; antiproliferative, anticarcinogenic, antiinflammatory, neuroleptic agent, autoimmune disorders | 4SC AG (DE) | 2010-02-23 | — | — | US | disclosed |
| CN-100556981-C | Based on red organic electrofluorescence material of triaromatic amine and benzothiazole and preparation method thereof | UNIV FUDAN (CN) | 2009-11-04 | — | — | CN | disclosed |
| EP-1861365-B1 | N-SULPHONYLPYRROLES AND THEIR USE AS HISTONE DEACETYLASE INHIBITORS | 4SC AG (DE) | 2009-07-01 | — | — | EP | disclosed |
| US-20090136448-A1 | Antiviral 2-Carboxy-Thiophene Compounds | CORFIELD JOHN ANDREW | 2009-05-28 | — | — | US | disclosed |
| EP-1381096-B1 | White organic light-emitting devices using a thin rubrene layer | EASTMAN KODAK CO (US) | 2008-10-01 | — | — | EP | disclosed |
| EP-1971599-A1 | ANTIVIRAL 2-CARBOXY-THIOPHENE COMPOUNDS | SmithKline Beecham Corporation (US) | 2008-09-24 | — | — | EP | disclosed |
| US-20080176848-A1 | e.g. N-Hydroxy-3-{1-[4-(1-methyl-1H-indol-5-yl)-benzenesulfonyl]-1H-pyrrol-3-yl}-acrylamide; antiproliferative, anticarcinogenic, antiinflammatory, neuroleptic agent, autoimmune disorders | NYCOMED GMBH (DE) | 2008-07-24 | — | — | US | disclosed |
| CN-101137623-A | N-sulphonylpyrroles and their use as histone deacetylase inhibitors | NYCOMED GMBH (DE) | 2008-03-05 | — | — | CN | disclosed |
| WO-2007147794-A1 | FURAN DERIVATIVES AND THEIR USE AS ANTIVIRAL AGENTS | SMITHKLINE BEECHAM CORPORATION (US) | 2007-12-27 | — | — | WO | disclosed |
| EP-1861365-A1 | N-SULPHONYLPYRROLES AND THEIR USE AS HISTONE DEACETYLASE INHIBITORS | Nycomed GmbH (DE) | 2007-12-05 | — | — | EP | disclosed |
| CN-101081977-A | Triaromatic amine and benzopyrene based red organic electroluminescent material and preparation method thereof | UNIV FUDAN (CN) | 2007-12-05 | — | — | CN | disclosed |
| WO-2007135529-A2 | AZABENZIMIDAZOLYL COMPOUNDS AS MGLUR2 POTENTIATORS | PFIZER PRODUCTS INC. (US) | 2007-11-29 | — | — | WO | disclosed |
| WO-2007135527-A2 | BENZIMIDAZOLYL COMPOUNDS | PFIZER PRODUCTS INC. (US) | 2007-11-29 | — | — | WO | disclosed |
| US-20070249639-A1 | Use of 9H-Purine-2,6-Diamine Derivatives in the Treatment of Proliferative Diseases and Novel 9H-Purine-2,6-Diamine Derivatives | BAENTELI ROLF | 2007-10-25 | — | — | US | disclosed |
| WO-2007088148-A1 | DERIVATIVES OF THIOPHENE CARBOXILIC ACID AS ANTIVIRAL AGENT | SMITHKLINE BEECHAM CORPORATION (US) | 2007-08-09 | — | — | WO | disclosed |
| WO-2007071434-A1 | ANTIVIRAL 2-CARBOXY-THIOPHENE COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2007-06-28 | — | — | WO | disclosed |
| WO-2007039146-A1 | 4-CARBOXY PYRAZOLE DERIVATIVES AS ANTI-VIRAL AGENTS | SMITHKLINE BEECHAM CORPORATION (US) | 2007-04-12 | — | — | WO | disclosed |
| US-7138425-B2 | Phthalimide carboxylic acid derivatives | OXFORD GLYCOSCIENCE (UK) LTD. (GB) | 2006-11-21 | — | — | US | disclosed |
| US-20060247210-A1 | such as (4-Benzothiazol-2-yl-1H-pyrazol-3-yl)-[2-(1H-imidazol-4-yl)-ethyl]-amine, used in the treatment of disorders associated with hyperproliferation and tissue remodelling or repair, inflammation, cell migration and invasion, and renal diseases, or as protein kinase inhibitors | QLT INC. (CA) | 2006-11-02 | — | — | US | disclosed |
| WO-2006097474-A1 | N-SULPHONYLPYRROLES AND THEIR USE AS HISTONE DEACETYLASE INHIBITORS | NYCOMED GMBH (DE) | 2006-09-21 | — | — | WO | disclosed |
| EP-1353908-B1 | PROCESSES AND SYNTHETIC INTERMEDIATES FOR PREPARING N-ARYLACRIDANCARBOXYLIC ACID DERIVATIVES | LUMIGEN INC (US) | 2006-03-08 | — | — | EP | disclosed |
| US-20050203153-A1 | Phthalimide carboxylic acid derivatives | OXFORD GLYCOSCIENCE (UK) LTD. (GB) | 2005-09-15 | — | — | US | disclosed |
| EP-1542997-A2 | PYRAZOLYLBENZOTHIAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | QLT, Inc. (CA) | 2005-06-22 | — | — | EP | disclosed |
| EP-1483261-A1 | PHTHALIMIDE CARBOXYLIC ACID DERIVATIVES | Oxford GlycoSciences (UK) Ltd, Attn: Mary Gadsden (GB) | 2004-12-08 | — | — | EP | disclosed |
| US-6727245-B2 | 4-(HETERO)ARYL-3-OXO-3,4-DIHYDROPYRIDO(2,3-B)PYRAZINE DERIVATIVES; PROPHYLACTIC OR THERAPEUTIC TREATMENT OF PHOSPHODIESTERASE IV AND TUMOR NECROSIS FACTOR MEDIATED DISEASES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-04-27 | — | — | US | disclosed |
| US-6720092-B2 | DEVICE COMPRISING SUBSTRATE, ANODE, HOLE INJECTING LAYER, HOLE TRANSPORT LAYER, YELLOW LIGHT-EMITTING LAYER INCLUDING RUBRENE OR DERIVATIVE, LIGHT-EMITTING LAYER DOPED WITH BLUE LIGHT-EMITTING COMPOUND, ELECTRON TRANSPORT LAYER, CATHODE | EASTMAN KODAK COMPANY | 2004-04-13 | — | — | US | disclosed |
| US-6692846-B2 | EXTENDED OPERATING LIFETIME WITHOUT AFFECTING COLOR | EASTMAN KODAK COMPANY | 2004-02-17 | — | — | US | disclosed |
| WO-2004011460-A2 | PYRAZOLYLBENZOTHIAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | QLT, INC. (CA) | 2004-02-05 | — | — | WO | disclosed |
| EP-1353908-A4 | PROCESSES AND SYNTHETIC INTERMEDIATES FOR PREPARING N-ARYLACRIDANCARBOXYLIC ACID DERIVATIVES | LUMIGEN INC (US) | 2004-01-28 | — | — | EP | disclosed |
| US-20040009367-A1 | WHITE ORGANIC LIGHT-EMITTING DEVICES USING RUBRENE LAYER | EASTMAN KODAK COMPANY | 2004-01-15 | — | — | US | disclosed |
| EP-1381096-A2 | White organic light-emitting devices using rubrene layer | EASTMAN KODAK COMPANY (US) | 2004-01-14 | — | — | EP | disclosed |
| US-20040001968-A1 | ORGANIC ELECTROLUMINESCENT DEVICE HAVING A STABILIZING DOPANT IN A HOLE-TRANSPORT LAYER OR IN AN ELECTRON-TRANSPORT LAYER DISTANT FROM THE EMISSION LAYER | EASTMAN KODAK COMPANY | 2004-01-01 | — | — | US | disclosed |
| EP-1353908-A1 | PROCESSES AND SYNTHETIC INTERMEDIATES FOR PREPARING N-ARYLACRIDANCARBOXYLIC ACID DERIVATIVES | LUMIGEN, INC. (US) | 2003-10-22 | — | — | EP | disclosed |
| WO-2003074516-A1 | PHTHALIMIDE CARBOXYLIC ACID DERIVATIVES | OXFORD GLYCOSCIENCES (UK) LTD (GB) | 2003-09-12 | — | — | WO | disclosed |
| EP-0770079-B1 | HETEROBICYCLIC DERIVATIVES | FUJISAWA PHARMACEUTICAL CO (JP) | 2003-02-12 | — | — | EP | disclosed |
| US-20020107251-A1 | Heterobicyclic derivatives | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-08-08 | — | — | US | disclosed |
| WO-2002059096-A1 | PROCESSES AND SYNTHETIC INTERMEDIATES FOR PREPARING N-ARYLACRIDANCARBOXYLIC ACID DERIVATIVES | LUMIGEN, INC. (US) | 2002-08-01 | — | — | WO | disclosed |
| US-6426345-B1 | PHOSPHODIESTERASE INHIBITORS; ANTIINFLAMMATORY AGENTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-07-30 | — | — | US | disclosed |
| US-6410732-B2 | FORMATION OF BOND BETWEEN NITROGEN ATOM OF ACRIDAN RING AND CARBON ATOM OF ANOTHER AROMATIC OR HETEROAROMATIC RING COMPOUND; ASSAYS FOR PEROXIDASE ENZYMES AND ENZYME INHIBITORS AND IN ASSAYS EMPLOYING ENZYME-LABELED SPECIFIC BINDING PAIRS | LUMIGEN, INC. | 2002-06-25 | — | — | US | disclosed |
| EP-0674635-B1 | QUINUCLIDINE DERIVATIVES AS SQUALENE SYNTHASE INHIBITORS | SYNGENTA LTD (GB) | 2001-03-28 | — | — | EP | disclosed |
| CN-1051548-C | Heterobicyclic derivatives, pharmaceutical compositions containing them, process for preparing them and their use | FUJISAWA PHARMACEUTICAL CO (JP) | 2000-04-19 | — | — | CN | disclosed |
| CN-1250776-A | Heterodicyclic compound derivatives | FUJISAWA PHARMACEUTICAL CO (JP) | 2000-04-19 | — | — | CN | disclosed |
| EP-0920867-A1 | Pyrido[2,3-a]pyrazine derivatives as PDE-IV and TNF inhibitors | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1999-06-09 | — | — | EP | disclosed |
| US-5847006-A | Therapeutic guanidines | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1998-12-08 | — | — | US | disclosed |
| EP-0746316-A4 | THERAPEUTIC GUANIDINES | CAMBRIDGE NEUROSCIENCE INC (US) | 1997-12-10 | — | — | EP | disclosed |
| EP-0476456-B1 | Substituted 2-thiazolyl tetrazolium salt indicators | BAYER AG (US) | 1997-11-12 | — | — | EP | disclosed |
| US-5679536-A | LABELING ANALYTE WITH PEROXIDASE; MEASURING CHEMILUMINESCENCE OF LUMINOL/HYDROGEN PEROXIDE CATALYZED BY PEROXIDASE | HITACHI CHEMICAL CO. LTD. (JP) | 1997-10-21 | — | — | US | disclosed |
| CN-1157617-A | Heterobicyclic derivatives | FUJISAWA PHARMACEUTICAL CO (JP) | 1997-08-20 | — | — | CN | disclosed |
| EP-0770079-A1 | HETEROBICYCLIC DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1997-05-02 | — | — | EP | disclosed |
| EP-0746316-A1 | THERAPEUTIC GUANIDINES | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1996-12-11 | — | — | EP | disclosed |
| EP-0476457-B1 | 2-Benzothiazolyl tetrazolium salt indicators | BAYER AG (US) | 1996-12-04 | — | — | EP | disclosed |
| WO-1996001825-A1 | HETEROBICYCLIC DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-01-25 | — | — | WO | disclosed |
| EP-0674635-A1 | QUINUCLIDINE DERIVATIVES AS SQUALENE SYNTHASE INHIBITORS | ZENECA LIMITED (GB) | 1995-10-04 | — | — | EP | disclosed |
| WO-1995014467-A1 | THERAPEUTIC GUANIDINES | CAMBRIDGE NEUROSCIENCE, INC. (US) | 1995-06-01 | — | — | WO | disclosed |
| EP-0650044-A2 | Chemiluminescent analytical method | Hitachi Chemical Co., Ltd. (JP) | 1995-04-26 | — | — | EP | disclosed |
| WO-1994014803-A1 | QUINUCLIDINE DERIVATIVES AS SQUALENE SYNTHASE INHIBITORS | ZENECA LIMITED (GB) | 1994-07-07 | — | — | WO | disclosed |
| US-5322680-A | Chromogenic detector for medical diagnosis by forming formazan dyes chemical reduction | MILES INC. (US) | 1994-06-21 | — | — | US | disclosed |
| US-5300637-A | Useful in determination of reducing substances | MILES INC. (US) | 1994-04-05 | — | — | US | disclosed |
| US-5185450-A | Tetrazolium compounds for cell viability assays | UNIVERSITY OF SOUTH FLORIDA (US) | 1993-02-09 | — | — | US | disclosed |
| EP-0476456-A2 | Substituted 2-thiazolyl tetrazolium salt indicators | Bayer Corporation (US) | 1992-03-25 | — | — | EP | disclosed |
| EP-0476457-A2 | 2-Benzothiazolyl tetrazolium salt indicators | Bayer Corporation (US) | 1992-03-25 | — | — | EP | disclosed |
| CN-1049495-A | Butyro-derivative | CIBA GEIGY AG (CH) | 1991-02-27 | — | — | CN | disclosed |
| US-4955987-A | FIBER-REACTIVE DYES FROM CYANURIC CHLORIDE AND AZO DYES IN THE PRESENCE OF LITHIUM HYDROXIDE, STORAGE STABIITY, MEMBRANE SEPARATION | CIBA-GEIGY CORPORATION (US) | 1990-09-11 | — | — | US | disclosed |
| US-4906737-A | Azo dye of the pyridone series containing a fluoro-s-triazinyl fibre-reactive group | CIBA-GEIGY CORPORATION (US) | 1990-03-06 | — | — | US | disclosed |
| CN-1005737-B | Process for printing and dyeing cellulosic fibre products | 西巴·盖尔基股份公司 | 1989-11-08 | — | — | CN | disclosed |
| CN-1005738-B | Printing method for cellulose fabric | 西巴·盖尔基股份公司 | 1989-11-08 | — | — | CN | disclosed |
| US-4877413-A | Process for the end-to-end dyeing of cellulosic fibres | CIBA-GEIGY CORPORATION (US) | 1989-10-31 | — | — | US | disclosed |
| US-4808706-A | WET- AND LIGHFAST; SOLUBLE | CIBA-GEIGY CORPORATION (US) | 1989-02-28 | — | — | US | disclosed |
| US-4736021-A | TEXTILES, LEATHER AND PAPER | CIBA-GEIGY CORPORATION (US) | 1988-04-05 | — | — | US | disclosed |
| US-4665162-A | DYES FOR LEATHER AND PAPER | SANDOZ LTD. (CH) | 1987-05-12 | — | — | US | disclosed |
| US-4659333-A | Process for fixing dyes and prints with hot steam containing air | CIBA-GEIGY CORPORATION (US) | 1987-04-21 | — | — | US | disclosed |
| US-4650859-A | WOOL,POLYAMIDES, LEATHER | CIBA-GEIGY CORPORATION (US) | 1987-03-17 | — | — | US | disclosed |
| US-4650859-A | WOOL,POLYAMIDES, LEATHER | CIBA-GEIGY CORPORATION (US) | 1987-03-17 | — | — | US | disclosed |
| US-4647285-A | Process for printing cellulosic fibres with reactive dye and C3-18 aliphatic carboxylate salt fixing agent | CIBA-GEIGY CORPORATION (US) | 1987-03-03 | — | — | US | disclosed |
| CN-85107872-A | The printing method of cellulose fibre (fabric) | — | 1986-07-09 | — | — | CN | disclosed |
| CN-85101905-A | The technology of printing cellulose fibres | — | 1986-06-10 | — | — | CN | disclosed |
| US-4588411-A | Long-shelflife print containing reactive dye and alkali acetate pastes and their use | CIBA-GEIGY CORPORATION (US) | 1986-05-13 | — | — | US | disclosed |
| US-4587292-A | AZO DYES | SANDOZ LTD. (CH) | 1986-05-06 | — | — | US | disclosed |
| US-4550158-A | DYE FOR PAPER AND LEATHER | SANDOZ LTD. (CH) | 1985-10-29 | — | — | US | disclosed |
| US-4525583-A | YELLOW-ORANGE DYE FOR PAPER | CIBA-GEIGY CORPORATION (US) | 1985-06-25 | — | — | US | disclosed |
| US-4507236-A | Fibre-reactive dyes, containing both chloro and fluoro triazine radicals | CIBA-GEIGY CORPORATION (US) | 1985-03-26 | — | — | US | disclosed |
| US-4485042-A | COLORFASTNESS | CASSELLA AKTIENGESELLSCHAFT (DE) | 1984-11-27 | — | — | US | disclosed |
| US-4325869-A | CONTAINING A PYRIMIDINE RING AND ONE OR MORE AZO GROUPS | CIBA-GEIGY CORPORATION (US) | 1982-04-20 | — | — | US | disclosed |
| US-4261889-A | TRIAZINE DYES FOR COTTON | CIBA-GEIGY CORP. (US) | 1981-04-14 | — | — | US | disclosed |
| US-4166803-A | Heterocyclic benzoate ultraviolet stabilizers and their use in organic compositions | EASTMAN KODAK COMPANY (US) | 1979-09-04 | — | — | US | disclosed |
| US-4129736-A | FIBER-REACTIVE | CIBA-GEIGY CORPORATION (US) | 1978-12-12 | — | — | US | disclosed |
| US-4099007-A | N,N-SUBSTITUTED 2,4,5-TRIKETOIMIDAZOLIDINES AND A PROCESS FOR THEIR PREPARATION | HOECHST AKTIENGESELLSCHAFT (DE) | 1978-07-04 | — | — | US | disclosed |
| US-4096130-A | N,N'substituted 2,4,5-triketoimidazolidines, corresponding resinous polymers and a process for their preparation | HOECHST AKTIENGESELLSCHAFT (DT) | 1978-06-20 | — | — | US | disclosed |
| US-4082739-A | FIBRE-REACTIVE DYESTUFF CONTAINING A BIS-TRIAZINYLAMINO | CIBA-GEIGY AG (CH) | 1978-04-04 | — | — | US | disclosed |
| US-4079051-A | 4-Halogeno-s-triazin-2-yl-phosphoramide acid containing reactive dyestuffs | CIBA-GEIGY CORPORATION (US) | 1978-03-14 | — | — | US | disclosed |
| US-4065427-A | Polychromophoric heterocyclic ultraviolet stabilizers and their use in organic compositions | EASTMAN KODAK COMPANY (US) | 1977-12-27 | — | — | US | disclosed |
| US-4033944-A | Fibre-reactive hydroxycycloalkenyl-halo triazinyl containing dyestuffs | CIBA-GEIGY CORPORATION (US) | 1977-07-05 | — | — | US | disclosed |
| US-4024153-A | ULTRAVIOLET STABILIZERS | EASTMAN KODAK COMPANY (US) | 1977-05-17 | — | — | US | disclosed |
| US-4018743-A | Process for preparing triketoimidazolidines | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-04-19 | — | — | US | disclosed |
| US-4000148-A | POLYMERS | EASTMAN KODAK COMPANY (US) | 1976-12-28 | — | — | US | disclosed |
| US-3981822-A | HETEROCYCLIC COMPOUNDS | EASTMAN KODAK COMPANY (US) | 1976-09-21 | — | — | US | disclosed |
| US-3969290-A | POLYMERS FROM OXAMIDIC ESTERS, POLYISOCYANATES, AND POLYBASIC CARBOXYLIC ACIDS | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-07-13 | — | — | US | disclosed |
| US-3954706-A | Polychromophoric benzotriazole ultraviolet stabilizers for organic compositions | EASTMAN KODAK COMPANY (US) | 1976-05-04 | — | — | US | disclosed |
| US-3947407-A | ANTHRAQUINONE DYE | CIBA-GEIGY AG (CH) | 1976-03-30 | — | — | US | disclosed |
| US-3947407-A | ANTHRAQUINONE DYE | CIBA-GEIGY AG (CH) | 1976-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (22 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10243151-B2 | Organic semiconductor material and light-emitting element, light-emitting device, lighting system, and electronic device using the same | OXA1L, BECN1, MAP1LC3A | RAB9A 3158/4885NPC1 4299/4885KDM4E 1958/4885 |
| US-20050203153-A1 | Phthalimide carboxylic acid derivatives | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, HCCS, IDH1 | RAB9A 1209/4885NPC1 2102/4885KDM4E 1348/4885 |
| US-20060247210-A1 | such as (4-Benzothiazol-2-yl-1H-pyrazol-3-yl)-[2-(1H-imidazol-4-yl)-ethyl]-amine, used in the treatment of disorders associated with hyperproliferation and tissue remodelling or repair, inflammation, cell migration and invasion, and renal diseases, or as protein kinase inhibitors | TST, PTK2, PTK2B | RAB9A 4041/4885NPC1 4326/4885KDM4E 1544/4885 |
| US-20150239880-A1 | LIGHT EMITTING MATERIAL, COMPOUND, AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | RER1, NR2E3, CRY1 | RAB9A 2041/4885NPC1 2873/4885KDM4E 2867/4885 |
| US-20170250352-A1 | Organic Semiconductor Material and Light-Emitting Element, Light-Emitting Device, Lighting System, and Electronic Device Using the Same | OXA1L, BECN1, MAP1LC3A | RAB9A 3158/4885NPC1 4299/4885KDM4E 1958/4885 |
| US-20100060155-A1 | Organic Semiconductor Material and Light-Emitting Element, Light-Emitting Device, Lighting System, and Electronic Device Using the Same | OXA1L, BECN1, MAP1LC3A | RAB9A 3158/4885NPC1 4299/4885KDM4E 1958/4885 |
| US-20120049768-A1 | Fluorene Derivative, Organic Compound, and Light-Emitting Element, Light-Emitting Device, and Electronic Device Using the Compound | AFF2, MAPRE2, AFF4 | RAB9A 440/4885NPC1 2154/4885KDM4E 2863/4885 |
| US-20210145799-A1 | PHARMACEUTICAL COMBINATION PRODUCTS COMPRISING A HISTONE DEACETYLASE (HDAC) INHIBITOR AND A TLR7 AGONIST AND/OR TLR8 AGONIST FOR THE TREATMENT OF CANCER | HDAC8, TLR8, TLR7 | RAB9A 3393/4885NPC1 2449/4885KDM4E 319/4885 |
| US-20130112961-A1 | Organic Semiconductor Material and Light-Emitting Element, Light-Emitting Device, Lighting System, and Electronic Device Using the Same | OXA1L, BECN1, MAP1LC3A | RAB9A 3158/4885NPC1 4299/4885KDM4E 1958/4885 |
| US-20080176848-A1 | e.g. N-Hydroxy-3-{1-[4-(1-methyl-1H-indol-5-yl)-benzenesulfonyl]-1H-pyrrol-3-yl}-acrylamide; antiproliferative, anticarcinogenic, antiinflammatory, neuroleptic agent, autoimmune disorders | HDAC1, H1-3, HDAC2 | RAB9A 3521/4885NPC1 4556/4885KDM4E 526/4885 |
| US-20210113528-A1 | Combination comprising HDAC inhibitor and CD137 agonist for cancer therapy | HDAC7, HDAC1, HDAC11 | RAB9A 1453/4885NPC1 781/4885KDM4E 786/4885 |
| US-20110178126-A1 | PYRAZOLYLBENZOTHIAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | REN, PGF, PKD1 | RAB9A 2638/4885NPC1 3923/4885KDM4E 1780/4885 |
| US-20090136448-A1 | Antiviral 2-Carboxy-Thiophene Compounds | EIF2AK2, HAVCR2, MAVS | RAB9A 1920/4885NPC1 1833/4885KDM4E 794/4885 |
| US-20130237572-A1 | PYRAZOLYLBENZOTHIAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | COXFA4L2, TYR, XDH | RAB9A 3096/4885NPC1 404/4885KDM4E 3729/4885 |
| US-20140350009-A1 | PYRAZOLYLBENZOTHIAZOLE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS | COXFA4L2, TYR, XDH | RAB9A 3096/4885NPC1 404/4885KDM4E 3729/4885 |
| US-20150329544-A1 | CYCLIC AZINE DERIVATIVES, PROCESSES FOR PRODUCING THESE, AND ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THESE AS COMPONENT | CPNE4, EPB41, AZI2 | RAB9A 1136/4885NPC1 3259/4885KDM4E 577/4885 |
| US-20120214993-A1 | CYCLIC AZINE DERIVATIVES, PROCESSES FOR PRODUCING THESE, AND ORGANIC ELECTROLUMINESCENT ELEMENT CONTAINING THESE AS COMPONENT | CPNE4, EPB41, AZI2 | RAB9A 1136/4885NPC1 3259/4885KDM4E 577/4885 |
| US-20070249639-A1 | Use of 9H-Purine-2,6-Diamine Derivatives in the Treatment of Proliferative Diseases and Novel 9H-Purine-2,6-Diamine Derivatives | HPRT1, NUDT1, DPYD | RAB9A 1519/4885NPC1 1910/4885KDM4E 1865/4885 |
| US-20100074862-A1 | N-SULPHONYLPYRROLES AND THEIR USE AS HISTONE DEACETYLASE INHIBITORS | HDAC1, HDAC3, HDAC2 | RAB9A 2473/4885NPC1 3578/4885KDM4E 120/4885 |
| US-20020107251-A1 | Heterobicyclic derivatives | ARSA, ARRB1, SULT2A1 | RAB9A 1092/4885NPC1 875/4885KDM4E 2663/4885 |
| US-20200261418-A1 | HDAC INHIBITOR IN COMBINATION WITH IMMUNE CHECKPOINT MODULATOR FOR CANCER THERAPY | HDAC4, HDAC5, HDAC9 | RAB9A 3549/4885NPC1 3394/4885KDM4E 77/4885 |
| US-20230201161-A1 | Combination comprising HDAC inhibitor, LAG-3 inhibitor and a PD-1 inhibitor or PD-L1 inhibitor for cancer treatment | HDAC1, HDAC3, HDAC11 | RAB9A 1283/4885NPC1 3699/4885KDM4E 126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.